SprooseLife Vitamins by Dr. Robert Vogel Launches New Formulations Targeting Heart, Nerve, and Cellular Health
SprooseLife Vitamins, founded by Dr. Robert Vogel, is dedicated to providing high-quality nutritional supplements that ...
Hosted on MSN3d
Everything You Need to Know About Supplements for Joint Pain
Supplements are widely used to manage joint pain, but the science on their effectiveness is limited. Here's what to know ...
Billed as nonaddictive, new pain pill could soon win FDA approval
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...
verywellhealth14d
Zepbound Gets FDA Approval to Treat Sleep Apnea
The Food and Drug Administration (FDA) on Dec. 20 approved the obesity medication Zepbound (tirzepatide) as the first pharmaceutical treatment for moderate-to-severe obstructive sleep apnea (OSA) in ...
Everyday Health19d
FDA Approves First Medication for Obstructive Sleep Apnea
The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...
Newsweek20d
Prebiotic Supplement Recall in 25 States as FDA Issues Risk Warning
A recall for a brand of supplements has been categorized as Class II by the FDA due to the possible presence of foreign objects. A bottle of herbal supplements is pictured. A recall for a brand of ...
Yahoo Finance20d
FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo
(Reuters) -The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's blockbuster cancer drug, Opdivo. Opdivo is part of a class of drugs ...
The Globe and Mail20d
U.S. FDA approves injectable version of cancer drug from Bristol Myers Squibb
The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb’s BMY-N blockbuster cancer drug, Opdivo. Opdivo is part of a class of ...
Targeted Oncology20d
FDA Approves Subcutaneous Nivolumab Across Existing Solid Tumor Indications
The FDA has approved the subcutaneous formulation of nivolumab (Opdivo). This approval makes it the first and only subcutaneously administered PD-1 inhibitor. Subcutaneous nivolumab is approved in all ...
U.S. News & World Report21d
FDA Approves Generic GLP-1 Medicine For Diabetes Treatment
THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for ...
New York Post21d
FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...
People22d
Zepbound Weight Loss Medication Approved by FDA to Treat Sleep Apnea
Sleep apnea “occurs when a person’s upper airway becomes blocked, causing pauses in breathing during sleep,” per the FDA. “Today’s approval marks the first drug treatment option for ...